SBIR/STTR After Reauthorization: What Changed and How to Compete
The SBIR/STTR programs went dark for roughly six months after their authorization lapsed on September 30, 2025 — no new solicitations, no new awards, agencies in limbo. Congress fixed that in April 2026 with a new reauthorization bill that didn’t just restart the programs, it changed several of the rules small businesses compete under. Here’s what’s actually different now.
The Lapse and the Fix
SBIR/STTR authority expired September 30, 2025, halting the programs for about six months while Congress worked out reauthorization. The fix came as the Small Business Innovation and Economic Security Act of 2026, which passed the Senate on March 3 and the House on March 17 before being signed into law on April 13, 2026. The new authorization extends both programs through September 30, 2031, and — practically useful for agencies that had funding backed up during the lapse — lets agencies carry leftover FY2026 SBIR/STTR funds into FY2027 rather than losing them.
The Biggest Structural Change: Strategic Breakthrough Awards
The new law creates a Phase II tier called the Strategic Breakthrough Award, available only through agencies with more than $100 million in required annual SBIR spending — meaning this applies at a handful of the largest SBIR agencies, not across the board. These awards can reach up to $30 million with performance periods up to 48 months, a scale well beyond a standard Phase II. To qualify, a company needs a prior Phase I or Phase II award already in hand, plus a 100% match of newly obtained funds — meaning you need to bring matching capital or follow-on investment to access this tier. For DoD specifically, a Strategic Breakthrough Award also requires a program-objective-memorandum funding commitment, tying the award to an actual budgeted DoD program rather than existing as a standalone research grant. Agency spending on this tier is capped at 0.5% of their extramural R&D budget, so it’s a targeted, limited pool rather than a broad new funding stream.
New Foreign-Influence Screening
The reauthorization adds mandatory screening of applicants and key personnel for ties to countries of concern. Any entity appearing on one of four specified federal watch lists is excluded from award eligibility. If your company is denied on security grounds, the law does provide a right to reapply, but plan for this screening step to add time to your award timeline and make sure any foreign funding relationships, foreign personnel, or foreign research partnerships are fully disclosed and reviewed internally before you submit, rather than discovered during agency due diligence.
The New Anti-“SBIR Mill” Proposal Caps
Starting in FY2027, individual agencies get authority to set their own caps on how many proposals a single company can submit per solicitation or per topic — a direct response to concern about so-called “SBIR mills,” firms that submit extremely high volumes of proposals as a strategy rather than pursuing a smaller number of genuinely well-matched opportunities. Agencies can waive this cap for up to 5% of topics in a given year, so the restriction isn’t absolute, but a company that has leaned on high-volume proposal submission as its primary strategy needs to rethink that approach heading into FY2027 and plan on a more targeted, higher-quality proposal pipeline instead.
What Hasn’t Changed
The core Phase I/Phase II/Phase III structure remains intact — Phase I for feasibility and proof of concept, Phase II for full research and development, and Phase III for commercialization (non-SBIR/STTR funded, drawing on follow-on contracts, private investment, or other sources). Commercialization expectations and due diligence requirements that followed earlier reauthorizations, including scrutiny introduced after the 2022 reauthorization, remain part of the program’s framework, and companies should continue tracking their Commercialization Plan and prior award performance carefully, since reviewers weigh a track record of translating research into actual products or follow-on contracts.
Practical Steps for Competing Under the New Rules
Review your company’s foreign personnel, funding sources, and research partnerships now, before you submit a new proposal, so foreign-influence screening doesn’t surface something late in the review process that could have been addressed earlier. If you’re a smaller, newer SBIR performer, don’t assume the Strategic Breakthrough Award tier is relevant to you — it specifically requires a prior Phase I/II award and matching funds, so it’s a second-stage opportunity, not an entry point. If your company has historically submitted a high volume of proposals per solicitation, start tightening your targeting now rather than waiting until the FY2027 caps take effect, since building a more selective pipeline takes time to develop.
Why This Matters Beyond the Immediate Reauthorization
SBIR/STTR has faced repeated near-lapses and short-term extensions over the past several years, and this reauthorization — running through September 2031 — is intended to provide more runway than the shorter extensions that preceded it. That said, the program’s history of periodic funding fights means it’s worth monitoring congressional appropriations and reauthorization news on an ongoing basis rather than assuming a multi-year extension removes all future uncertainty.
What the Six-Month Lapse Actually Meant for Companies Mid-Award
For companies with an active Phase I or Phase II award already obligated before the September 2025 lapse, existing funding generally continued flowing under already-signed agreements — the lapse primarily blocked new solicitations and new awards rather than clawing back money already committed. The practical pain fell hardest on companies that were mid-proposal or waiting on a decision when the authority expired: those proposals sat in limbo for roughly six months with no clear resolution date until the reauthorization bill actually passed. If your company was in that position, it’s worth checking directly with your program office on where your specific proposal landed in the backlog, since agencies are still working through accumulated volume from the lapse period.
How to Think About the Strategic Breakthrough Tier If You’re Not There Yet
Most small businesses reading about the new Strategic Breakthrough Award tier are not yet eligible for it, and that’s fine — it’s explicitly designed as a second-stage opportunity for companies that already have a Phase I or Phase II award and can bring matching funds to the table, not as a new entry point into the SBIR ecosystem. If you’re earlier in your SBIR journey, the more useful planning move is building toward that eligibility over time: successfully completing a Phase I, positioning for Phase II, and building relationships with investors or follow-on funding sources so that if your technology does mature to the point where a $30 million award makes sense, you’re not scrambling to find a matching-funds partner at the last minute.
Bottom Line
SBIR/STTR is back and extended through 2031, but it’s not the same program it was before the lapse — a new high-dollar Strategic Breakthrough Award tier for established performers, mandatory foreign-influence screening for everyone, and agency-set proposal caps arriving in FY2027 are all real changes to plan around, not just procedural footnotes.
Related reading: building your cost case for a federal award? See our guide to building a government cost proposal.
